Octant

Developer of synthetic technology designed to improve health and treat disease. The company's platform uses synthetic biology, genome engineering, sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells, enabling scientists to apply machine learning methods to engineer small molecules that interact with multiple receptors and unlock ways to treat complex diseases.

Lux Capital

SV Angel

Andreessen Horowitz

8VC

🏥 Healthcare